Evidence summaries: unlicensed and off-label medicines – Integrated process statement

This integrated process statement has been produced to explain how 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs) are developed. It provides an overview of the key process principles and describes all stages of development for ESUOMs.

This is not the current process. From February 2017, evidence summaries were developed using the evidence summaries: process guide.

Last reviewed: 2 March 2017